Last updated on November 2019

A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis


Brief description of study

The purpose of this study is to test any good and bad effects of the study drugs called ruxolitinib and thalidomide. Ruxolitinib and thalidomide could shrink the cancer, but it could also cause side effects.

Clinical Study Identifier: NCT03069326

Find a site near you

Start Over

Memorial Sloan Kettering Commack

Commack, NY United States
7.02miles
  Connect »